Thalidomide induces apoptosis in human monocytes by using a cytochrome c-dependent pathway.
about
Thalidomide and thalidomide analogues for induction of remission in Crohn's diseaseThalidomide for induction of remission in Crohn's diseaseThalidomide attenuates nitric oxide-driven angiogenesis by interacting with soluble guanylyl cyclase.Apoptosis-inducing activity of clofazimine in macrophages.Mechanism of immunomodulatory drugs' action in the treatment of multiple myeloma.Apoptosis modulation as a promising target for treatment of systemic sclerosis.Tumor necrosis factor-alpha promotes survival in methotrexate-exposed macrophages by an NF-kappaB-dependent pathway.Cell death signaling and anticancer therapyThalidomide induces limb anomalies by PTEN stabilization, Akt suppression, and stimulation of caspase-dependent cell deathTreatment of plasma cell dyscrasias with lenalidomide.Targeted therapies in multiple myeloma.Biological evaluation of both enantiomers of fluoro-thalidomide using human myeloma cell line H929 and others.Guanosine 5'-triphosphate induces differentiation-dependent apoptosis in human leukemia U937 and KG1 cells.Thalidomide inhibits adipogenesis of orbital fibroblasts in Graves' ophthalmopathy.Thalidomide prevents formation of multinucleated giant cells (Langhans-type cells) from cultured monocytes: possible pharmaceutical applications for granulomatous disorders.Monocytes from patients with myelodysplastic syndromes are more resistant to inhibition by thalidomide.Drug-regulatable cancer cell death induced by BID under control of the tissue-specific, lung cancer-targeted TTS promoter system.NF-kappaB protects Behçet's disease T cells against CD95-induced apoptosis up-regulating antiapoptotic proteins.Thalidomide enhances the anti-tumor activity of standard chemotherapy in a human melanoma xenotransplatation model.Dexamethasone -induced apoptosis of human monocytes exposed to immune complexes. Intervention of CD95- and XIAP-dependent pathways.
P2860
Q24241766-21466736-EFDB-4EB4-BD46-93B30F6F2D25Q24242218-C0C191FF-D322-43C8-8F3A-B112FE2507D8Q33569519-BB5FB6A8-7561-438C-B33F-20A029B9E22BQ33937772-0B1C0A63-9595-48BD-AC4D-FDADE0CD40BAQ35171777-6BA4CC11-D475-4A84-9DDB-7541CCAA4502Q35207610-C647FDA5-DDA2-47B1-ABB0-7C3A189AD1D4Q35620332-7A0BE27C-B384-40B8-9F8E-39215C3DE77EQ35972102-009BC455-A61D-43EA-A68B-017DFBC9BED6Q36421389-F6A6C432-BB9E-4C8F-AAE5-C8D741C771C9Q37176044-72BFBF0A-861D-4CAD-8228-06962141096FQ37431609-E09C11D1-3A9E-4620-BBA1-16227D115F5AQ38649220-FA9A1292-EFC0-4E80-9E8A-7E76688B3373Q40241248-BA93D0A9-F29F-495D-8CF4-6474EAEB2A46Q42801091-D96CEB54-317A-4FBE-90B3-AF125511ACAFQ43263191-E0E02F06-49B4-4C16-B8BA-79C83B5FB762Q43267275-9EAA509D-1475-4736-B869-650E4449099BQ45886892-6DF04D89-75D1-4F1D-8EE2-EA4D019456A5Q46573592-45F4C5D5-9BA0-47F8-B25B-C7E99C79F3FBQ46648179-A7F5D3BE-B08D-4104-A471-E21CE4ABF2DCQ46705014-6D64AA52-9395-4139-A257-D25E4D5426E8
P2860
Thalidomide induces apoptosis in human monocytes by using a cytochrome c-dependent pathway.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Thalidomide induces apoptosis ...... ytochrome c-dependent pathway.
@en
Thalidomide induces apoptosis ...... ytochrome c-dependent pathway.
@nl
type
label
Thalidomide induces apoptosis ...... ytochrome c-dependent pathway.
@en
Thalidomide induces apoptosis ...... ytochrome c-dependent pathway.
@nl
prefLabel
Thalidomide induces apoptosis ...... ytochrome c-dependent pathway.
@en
Thalidomide induces apoptosis ...... ytochrome c-dependent pathway.
@nl
P2093
P1476
Thalidomide induces apoptosis ...... ytochrome c-dependent pathway.
@en
P2093
Andreas Lügering
Henning R Gockel
Jan Heidemann
Michael Schmidt
Norbert Lügering
Torsten Kucharzik
P304
P356
10.4049/JIMMUNOL.172.8.5103
P407
P577
2004-04-01T00:00:00Z